OOIR: Observatory of International Research

Papers

(The H4-Index of Cellular Oncology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)

Article	Citations
Angiogenesis as a hallmark of solid tumors - clinical perspectives	132
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities	76
Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN	75
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance	54
The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications	52
Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma	51
A comprehensive review of SHP2 and its role in cancer	47
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis	39
CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities	38
HDAC6: A unique HDAC family member as a cancer target	35
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment	34
Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma	33
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers	30
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer	29
Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells	28
Protein arginine methyltransferase 5: a potential cancer therapeutic target	28
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing	28
How VEGF-A and its splice variants affect breast cancer development – clinical implications	26
Clinical perspectives of BET inhibition in ovarian cancer	26
The Duchenne muscular dystrophy gene and cancer	26
YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin	26
Circular RNA circNFATC3 acts as a miR-9-5p sponge to promote cervical cancer development by upregulating SDC2	25
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer	25
Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy	25